On the heels of selling HRB brands to Sodalis in a rumored $100 million deal, Tengram has sold RéVive Skincare to the China-based conglomerate S'Young Group.WHO: Launched in 1997, RéVive Skincare is a luxury skincare line developed by Dr. Gregory Bays Brown, a plastic and reconstructive surgeon, created to bring back the glow of youth. Each product has been scientifically formulated with Bio-Renewal Technology, inspired by patented and Nobel Prize–winning science that Dr. Brown used to heal burn victims. This breakthrough technology delivers fast results to help change the behavior of skin and restore skin’s youthful glow. RéVive is distributed domestically at luxury retailers Neiman Marcus, Saks, Bergdorf Goodman, Bluemercury, and Cos Bar, and select retailers in Canada, UK, Europe, and Asia.Tengram Capital Partners and its predecessor and successor, Windsong Global, are private equity firms exclusively focused on investments in leading middle-market consumer companies that own strong, recognizable brands. Tengram and Windsong invest in traditional "growth," but also in "restructuring/turnaround" and “carve-out” situations. Other investments include Algenist Beauty, Lilah B, Lime Crime, JVN Beauty, Pipette Baby, and Cos Bar.In addition to being one of the most successful manufacturers of facial mask brands in China, the S'Young Group is also the online distributor for beauty brands including Johnson & Johnson China, Fenty Beauty, Dr. Ci:Labo, Albion, Neutrogena, Kiko, and Lumene. Sales for the company overall were estimated to be $640.5 million in 2023.DETAILS:Tengram has sold RéVive Skincare to the S'Young Group.Dr.